229920002676 Complementary DNA Polymers 0.000 claims description 101.125000003275 alpha amino acid group Chemical group 0.000 claims description 191.230000014509 gene expression Effects 0.000 claims description 197.108091006028 chimera Proteins 0.000 claims abstract description 21.108020004707 nucleic acids Proteins 0.000 claims abstract description 86.150000007523 nucleic acids Chemical class 0.000 claims abstract description 234.229920001850 Nucleic acid sequence Polymers 0.000 claims abstract description 235.108090001123 antibodies Proteins 0.000 claims abstract description 364.102000004965 antibodies Human genes 0.000 claims abstract description 364.229920001184 polypeptide Polymers 0.000 title claims abstract description 826.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US17209699P priority Critical Priority to PCT/US1999/031274 priority patent/WO2000053752A2/en Priority to US17548100P priority Priority to PCT/US2000/004341 priority patent/WO2000053756A2/en Priority to PCT/US2000/005841 priority patent/WO2000053758A2/en Priority to US19100700P priority Priority to PCT/US2000/007532 priority patent/WO2000070050A1/en Priority to PCT/US2000/015264 priority patent/WO2000073452A2/en Priority to US21380700P priority Priority to US64484800A priority Priority to PCT/US2000/023328 priority patent/WO2001016318A2/en Priority to US24283700P priority Priority to PCT/US2000/030873 priority patent/WO2001040465A2/en Priority to US25364600P priority Priority to PCT/US2000/032678 priority patent/WO2001040466A2/en Application filed by Genentech Inc filed Critical Genentech Inc Priority to EP00989401A priority patent/EP1240325B1/en Publication of EP1897943A2 publication Critical patent/EP1897943A2/en Publication of EP1897943A3 publication Critical patent/EP1897943A3/en Application granted granted Critical Publication of EP1897943B1 publication Critical patent/EP1897943B1/en Links Original Assignee Genentech Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Yansura Current Assignee (The listed assignees may be inaccurate. Hillan Daniel Tumas Menno Van Lookeren Richard L. ( en Inventor Jian Chen Ellen Filvaroff Sherman Fong Audrey Goddard Paul J. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number EP07016899A Other languages German ( de)
#Esoteric software spine one skeleton multiple poses pdf
Google Patents IL-17 homologous polypeptides and therapeutic uses thereofĭownload PDF Info Publication number EP1897943A2 EP1897943A2 EP07016899A EP07016899A EP1897943A2 EP 1897943 A2 EP1897943 A2 EP 1897943A2 EP 07016899 A EP07016899 A EP 07016899A EP 07016899 A EP07016899 A EP 07016899A EP 1897943 A2 EP1897943 A2 EP 1897943A2 Authority EP European Patent Office Prior art keywords polypeptide cell acid sequence antibody pro Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents EP1897943A2 - IL-17 homologous polypeptides and therapeutic uses thereof EP1897943A2 - IL-17 homologous polypeptides and therapeutic uses thereof
0 kommentar(er)
